Long-term outcome and quality-adjusted life years after severe sepsis

Critical Care Medicine

Volumn 37, Issue 4, 2009, Pages 1268-1274

  Karlsson, Sari ^a   Ruokonen, Esko ^b   Varpula, Tero ^c   Ala Kokko, Tero I ^d   Pettilä, Ville ^c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

EuroQol 5D; Outcome; Quality of life; Quality adjusted life years; Severe sepsis

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SEPSIS; STRUCTURED QUESTIONNAIRE; SURVIVOR; VISUAL ANALOG SCALE;

FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEPSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS;

EID: 67650503830     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31819c13ac     Document Type: Article

References (43)

1. Bernard G, Vincent JL, Laterre PF, et al; for the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (Prowess) Study Group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709
2. Rivers E, Nguyen B, Havstadt S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
3. Vincent JL: Endpoints in sepsis trials: More than just 28-day mortality? Crit Care Med 2004; 32:S209-S213
4. Marshall JC, Vincent JL, Guyatt G, et al: Outcome measures for clinical research in sepsis: A report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med 2005; 33:1708-1716
5. Hofhuis JGM, Spronk PE, van Stel HF, et al: Quality of life before intensive care unit admission is a predictor of survival. Crit Care 2007; 11:R78
6. Niskanen M, Ruokonen E, Takala J, et al: Quality of life after prolonged intensive care. Crit Care Med 1999; 27:1132-139
7. Eddleston JM, White PP, Guthrie E: Survival, morbidity and quality of life after discharge from intensive care. Crit Care Med 2000; 28:2293-2299
8. Graf J, Koch M, Dujardin R, et al: Health- related quality of life before, 1 month after, and 9 months after intensive care in medical cardiovascular and pulmonary patients. Crit Care Med 2004; 31:2163-2169 9. Black NA, Jenkinson C, Hayes JA, et al: Review of outcome measures in adult critical care. Crit Care Med 2001; 29:2119-2124
9. Angus DC, Carlet J; on behalf of the 2002 Brussels Roundtable Participants: Surviving intensive care: A report from the 2002 Brussels Roundtable. Intensive Care Med 2003; 29:368-377
10. Anonymous: Understanding costs and cost-effectiveness in critical care. Report from the Second American Thoracic Society Workshop on Outcomes Research. Am J Respir Crit Care Med 2002; 165:540-550
11. Karlsson S, Varpula M, Ruokonen E, et al; for Finnsepsis Study Group: Incidence, treatment and outcome of severe sepsis in ICU treated adults in Finland: The Finnsepsis study. Intensive Care Med 2007; 33:435-443
12. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
13. Knaus WA, Draper EA, Wagner DB, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
14. Le Gall JR, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on a European/North American multi-center study. JAMA 1993; 270:2957-2963
15. Vincent J-L, De Mendonca A, Cantraine F, et al: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26:1793-1800
16. Statistics Finland. Available at: http://www.tilastokeskus.fi/tup/ tilastotietokannat/index/html. Accessed January 15, 2008
17. Ohinmaa A, Sintonen H: Quality of life of Finnish Population Measures by EuroQol. In: EuroQol, Plenary Meeting. Badia X, Herd-man M, Segura A (Eds). Discussion papers, Catalan Institute of Public Health, Barcelona, 1996, pp 161-172
18. The EuroQol Group: EuroQol, a new facility for the measurement of health-related quality of life. Health Policy 1990; 16:199-208
19. Cullen DJ, Civetta JM, Briggs BA, et al: Therapeutic intervention scoring system: A method for quantitative comparison of patient care. Crit Care Med 1974; 2:57-60
20. Garcia Lizana F, Peres Bota D, De Cubber M, et al: Long-term outcome in ICU patients: What about quality of life? Intensive Care Med 2003; 29:1286-1293
21. Cuthbertson BH, Scott J, Strachan M, et al: Quality of life before and after intensive care. Anaesthesia 2005; 60:332-339
22. Graf J, Wagner J, Graf C, et al: Five year survival, quality of life, and individual costs of 303 consecutive medical intensive care patients - A cost-utility analysis. Crit Care Med 2005; 33:547-555
23. Kaarlola A, Tallgren M, Pettilä V: Long-term survival, quality of life, and quality-adjusted life years among critically ill elderly patients. Crit Care Med 2006; 34:2120-2126
24. Korošec Jagodič H, Jagodič K, Podbregar M: Long-term outcome and quality of life of patients treated in surgical intensive care: A comparison between sepsis and trauma. Crit Care 2006; 10:R134
25. Weycker D, Akhras KS, Edelsberg J, et al: Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 2003; 31:2316-2322
26. Granja C, Dias C, Costa-Pereira A, et al: Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness. Crit Care 2004; 8:R91-R98
27. Heyland DK, Hopman W, Coo H, et al: Long-term health-related quality of life in survivors of sepsis. Short-Form 36: A valid and reliable measure of health-related quality of life. Crit Care Med 2000; 28:3599-3605
28. Rublee D, Opal SM, Schramm W, et al: Quality of life effects of antithrombin III in sepsis survivors: Results from the Kyper-Sept trial [ISRCTN22931023]. Crit Care 2002; 6:349-356
29. Angus DC, Musthafa AA, Clermont G, et al: Quality adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163:1389-1394
30. Bagshaw SM: The long-term outcome after acute renal failure. Curr Opin Crit Care 2006; 12:561-566
31. Åhlström A; Tallgren M, Peltonen S, et al: Survival and quality of life of patients requiring acute renal replacement therapy. Intensive Care Med 2005; 31:1222-1228
32. Dowdy DW, Eid MP, Sedrakyan A, et al: Quality of life in adult survivors of critical illness: A systematic review of the literature. Intensive Care Med 2005; 31:611-620
33. EuroQOL website. Available at: http://www.euroqol.org. Accessed January 15, 2008
34. Hofhuis JG, Spronk PE, van Stel HF, et al: The impact of critical illness on perceived health related quality of life during ICU treatment, hospital stay, and after hospital discharge: A long term follow-up study. Chest 2008; 133:377-385
35. Kaarlola A, Pettilä V, Kekki P: Quality of life six years after intensive care. Intensive Care Med 2003; 29:1294-1299
36. Flaatten H, Kvåle R: Survival and quality of life 12 years after ICU. A comparison with the general Norwegian population. Intensive Care Med 2001; 27:1005-1011
37. Angus DC, Linde-Zwirble WT, Clermont G, et al: Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med 2003; 31:1-11
38. Talmor T, Shapiro N, Greenberg D, et al: When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature. Crit Care Med 2006; 34:2738-2747
39. Fowler RA, Hill-Popper M, Stasinos J, et al: Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis. J Crit Care 2003; 18:181-191
40. Manns BJ, Lee H, Doig CJ, et al: An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 2002; 347:993-1000
41. Hofhuis J, Hautvast JL, Schrijvers AJ, et al: Quality of life on admission to the intensive care: Can we query the relatives? Intensive Care Med 2003; 29:974-979
42. Badia X, Diaz-Prieto A, Gorriz MT, et al: Using the EuroQol-5D to measure changes in quality of life 12 months after discharge from an intensive care unit. Intensive Care Med 2001; 27:1901-1907
43. Niskanen M, Kari A, Halonen P: Five-year survival after intensive care-comparison of 12,180 patients with the general population. Finnish ICU Study Group. Crit Care Med 1996; 24:1962-1967